Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids

Fraser J H Brims ¹, Anoop J Chauhan ², Bernard R Higgins Mr³ and Janis K Shute ^3*

¹ Portsmouth Hospitals NHS Trust, United Kingdom
² Portsmouth Hospitals NHS Trust; University of Portsmouth, United Kingdom
³ University of Portsmouth, United Kingdom

^* To whom correspondence should be addressed. E-mail: jan.shute{at}port.ac.uk.

Accepted 24 July 2009

Abstract

Background: There is evidence of activation of the extrinsic coagulation cascade in the asthmatic airway and both plasma and locally-derived factors may be involved. We tested the hypothesis that the normal haemostatic balance of healthy airways sampled by sputum induction favours fibrin formation in asthmatic airways, and that inhaled corticosteroids (ICS) and plasma exudation influence this balance.

Methods: ELISA and activity assays were used to measure alpha-2-macroglobulin (an index of plasma leakage) and coagulation factors in hypertonic saline-induced sputum of 30 stable subjects (10 controls, 10 moderate and 10 severe asthmatics). Additionally, the moderate cohort were weaned off their ICS, followed by further sputum induction 5 days after cessation of steroids.

Results: ICS wean induced a significant rise in plasminogen (median (IQR): 13.92 (6.12-16.17) vs. 4.82 (2.14-13.32) ng/ml; 95% CI 0.003 to 8.596, p=0.0499) and tissue-plasminogen activator (tPA; 5.57 (3.57-14.35) vs. 3.88 (1.74-4.05) ng/ml; 95% CI 0.828 to 9.972, p=0.0261) levels in sputum, such that tPA in untreated moderate asthma was significantly (p=0.0029) higher than normal (2.14 (0.0-2.53) ng/ml). Severe asthmatics had significantly more alpha-2 macroglobulin (p=0.0003), tissue factor (p=0.023), plasminogen activator inhibitor (p=0.0091) thrombin activatable fibrinolysis inhibitor (p=0.0031) and fibrin degradation products (p=0.0293) in their sputum than control subjects.

Conclusion: Untreated moderate asthma is associated with increased fibrinolysis that is corrected by ICS. Severe asthma and high dose corticosteroid therapy is associated with a pro-fibrinogenic, anti-fibrinolytic environment in the airways. Our study suggests that inhibition of fibrin deposition in severe asthma may be a therapeutic approach.